Healthcare & Medical Devices Global On demand · 24-48h

Global Needles and Blood Collection Tubes Market Strategic Research Report

Global Needles and Blood Collection Tubes Market Strategic R…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Needles and Blood Collection Tubes Market
$6.91B2025
6.8%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Blood Collection Needles, Blood Collection Tubes

By Application: Hospital & Clinic, Third-party Laboratory, Other

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: BD, Greiner Bio One, Cardinal Health, Sekisui, Sarstedt, FL Medical, Hongyu Medical, Improve Medical, TUD, Sanli, Gong Dong, CDRICH, WEGO, B. Braun, Terumo, Nipro, Smiths Medical, Berpu, Shanghai KDL

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 136 pages
Market size 2025
$6.91B
Billion USD
Forecast CAGR
6.8%
2025-2032
Forecast 2032
$11B
Projected
Regiones
5
Asia Pacific · Latin America · MEA · Europe · North America

Vista general

Scope of the Report

The global Needles and Blood Collection Tubes market size is predicted to grow from US$ 6,908 million in 2025 to US$ 10,920 million in 2032; it is expected to grow at a CAGR of 6.8% from 2026 to 2032.

Needles and Blood Collection Tubes are essential medical devices used in healthcare for obtaining blood samples from patients. Needles are typically hollow and sterile, designed for safe penetration of the skin and vein to collect blood. Blood collection tubes are specialized containers, often vacuum-sealed, that store and preserve the blood sample for analysis. These tubes may contain additives, such as anticoagulants or clot activators, depending on the type of diagnostic test required.

Market Drivers

The needles and blood collection tubes market is driven by the rising demand for diagnostic testing and blood sampling due to the increasing prevalence of chronic diseases, infectious diseases, and lifestyle disorders. The growing emphasis on preventive healthcare and early disease detection has led to a surge in the number of blood tests performed globally. Furthermore, advancements in healthcare infrastructure, particularly in emerging economies, coupled with the adoption of safe and efficient blood collection practices, are fueling market growth. The expansion of point-of-care testing and home-based healthcare services also contributes to the rising demand for high-quality needles and collection tubes.

Market Challenges

Despite its growth potential, the market faces challenges such as the high cost of advanced blood collection systems, which can limit adoption in low-income regions. Additionally, the risk of needlestick injuries and concerns about contamination or improper disposal pose significant barriers to market expansion. Stringent regulatory requirements and the need for compliance with international safety standards further add to the complexities faced by manufacturers. Supply chain disruptions, particularly during global crises such as pandemics, have also highlighted the vulnerability of the market.

Industry Trends

Key industry trends include the development of innovative products such as vacuum-based blood collection systems, which improve efficiency and reduce contamination risks. The market is also witnessing a shift toward single-use, disposable products to ensure safety and hygiene. Sustainability is becoming a focal point, with manufacturers exploring biodegradable and eco-friendly materials for blood collection tubes. Additionally, digital integration and smart labeling technologies are enhancing traceability and accuracy in blood sampling and analysis processes. These trends, combined with the growing adoption of minimally invasive techniques, are reshaping the needles and blood collection tubes market.

This report presents a comprehensive overview of the global Needles and Blood Collection Tubes market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Blood Collection Needles
  • Blood Collection Tubes

Segment by players, this report covers

  • BD
  • Greiner Bio One
  • Cardinal Health
  • Sekisui
  • Sarstedt
  • FL Medical
  • Hongyu Medical
  • Improve Medical
  • TUD
  • Sanli
  • Gong Dong
  • CDRICH
  • WEGO
  • B. Braun
  • Terumo
  • Nipro
  • Smiths Medical
  • Berpu
  • Shanghai KDL

Segment by Application

  • Hospital & Clinic
  • Third-party Laboratory
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Needles and Blood Collection Tubes market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Hospital & Clinic, Third-party Laboratory, Other evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Needles and Blood Collection Tubes Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 6.8%
Regional growth momentum
Market share by segment
Key metrics
Base value
$6.91B
2025
Forecast
$11B
2032
CAGR
6.8%
2025–2032
Regiones
5
global
Key companies
BDGreiner Bio OneCardinal HealthSekisuiSarstedtFL MedicalHongyu MedicalImprove Medical
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Blood Collection NeedlesBlood Collection Tubes
By Application
Hospital & ClinicThird-party LaboratoryOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Blood Collection Needles
  • 3.1.3 Blood Collection Tubes
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Hospital & Clinic
  • 4.1.3 Third-party Laboratory
  • 4.1.4 Other
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 BD
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Greiner Bio One
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Cardinal Health
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Sekisui
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Sarstedt
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 FL Medical
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Hongyu Medical
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Improve Medical
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 TUD
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Sanli
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Gong Dong
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 CDRICH
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 WEGO
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 B. Braun
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Terumo
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Nipro
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Smiths Medical
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Berpu
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 Shanghai KDL
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Needles and Blood Collection Tubes market size?
The global Needles and Blood Collection Tubes market is estimated at US$ 6.91 billion in 2025 (base year) and is projected to reach US$ 10.92 billion by 2032.
What growth rate is expected for the Needles and Blood Collection Tubes market through 2032?
The market is expected to grow at a CAGR of 6.8% from 2026 to 2032, expanding from US$ 6.91 billion in 2025 to US$ 10.92 billion in 2032, roughly 1.6 times its base-year value.
How is Needles and Blood Collection Tubes defined?
Needles and Blood Collection Tubes are essential medical devices used in healthcare for obtaining blood samples from patients. Needles are typically hollow and sterile, designed for safe penetration of the skin and vein to collect blood. Blood collection tubes are specialized containers, often vacuum-sealed, that store and preserve the blood sample for analysis.
What are the main segments of the Needles and Blood Collection Tubes market by type?
By type, the market is segmented into Blood Collection Needles and Blood Collection Tubes.
Which applications drive demand in the Needles and Blood Collection Tubes market?
Key applications covered include Hospital & Clinic, Third-party Laboratory and Other.
Who are the key players in the Needles and Blood Collection Tubes market?
Key players profiled include BD, Greiner Bio One, Cardinal Health, Sekisui, Sarstedt, FL Medical, Hongyu Medical and Improve Medical, among 19 companies covered in total.
Which regions and countries are covered for Needles and Blood Collection Tubes?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Needles and Blood Collection Tubes market?
The needles and blood collection tubes market is driven by the rising demand for diagnostic testing and blood sampling due to the increasing prevalence of chronic diseases, infectious diseases, and lifestyle disorders.
What challenges does the Needles and Blood Collection Tubes market face?
Despite its growth potential, the market faces challenges such as the high cost of advanced blood collection systems, which can limit adoption in low-income regions.
Who should buy the Needles and Blood Collection Tubes market report?
The report is intended for manufacturers and solution providers, distributors and end users in Hospital & Clinic, Third-party Laboratory and Other, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Needles and Blood Collection Tubes market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3.500,00 US$
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.